Skip Navigation

Profile

Michael D. Chan, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

162 Ratings
12 Comments
 

Michael D. Chan, M.D.

Associate Professor,

Clinical Interests

Brain Tumors

Contact Information

Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: mchan@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., Johns Hopkins University, 1998
  • M.D., New York University School of Medicine, 2004

Board Certifications

  • American Board of Radiology, Radiation Oncology

NPI Number

  • 1225151152
Michael D. Chan, M.D.

Doctor Rating

4.8 out of 5

162 Ratings
12 Comments
 

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Research Interests

Radiosurgery; Brain Neoplasms; Glioblastoma; Meningioma; Trigeminal Neuralgia
More »

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: mchan@wakehealth.edu

Recent Publications

Emerging indications for fractionated gamma knife radiosurgery. McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;80(2):210-216.

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neuro Oncol. 2017;19(4):558-566.

Multi-institutional nomogram predicting survival free from salvage whole brain radiation after radiosurgery in patients with brain metastases. Gorovets D, Ayala-Peacock D, Tybor DJ, Rava P, Ebner D, Cielo D, Noren G, Wazer DE, Chan M, Hepel JT.. Int J Radiat Oncol Biol Phys. 2017;97(2):246-253.

Stereotactic radiosurgical treatment of glomus jugulare tumors. Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER.. Otol Neurotol. 2017;38(4):555-562.

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Med Imaging Radiat Oncol. 2017;():.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.. Am J Clin Oncol. 2017;():.

The evolving role for re-irradiation in the management of recurrent grade 4 glioma. Howard SP, Krauze A, Chan MD, Tsien C, Tome WA.. J Neurooncol. 2017;():.

The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD.. Cancer Med. 2017;6(5):944-952.

Biology and treatment of metastasis of sarcoma to the brain. Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S.. Front Biosci (Elite Ed). 2016;8():233-244.

Recent advances in radiosurgical management of brain metastases. Devoid HM, McTyre ER, Page BR, Metheny-Barlow L, Ruiz J, Chan MD.. Front Biosci (Schol Ed). 2016;8():203-214.

Treatment of brain metastases of lung cancer in the era of precision medicine. Haughton ME, Chan MD, Watabe K, Bonomi M, Debinski W, Lesser GJ, Ruiz J.. Front Biosci (Elite Ed). 2016;8():219-232.

Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW.. Cancers (Basel). 2016;8(2):E22.

Pseudo progression identification of glioblastoma with dictionary learning. Zhang J, Yu H, Qian X, Liu K, Tan H, Yang T, Wang M, Li KC, Chan MD, Debinski W, Paulsson A, Wang G, Zhou X.. Comput Biol Med. 2016;73():94-101.

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study. Qian X, Tan H, Zhang J, Liu K, Yang T, Wang M, Debinskie W, Zhao W, Chan MD, Zhou X.. Oncotarget. 2016;7(34):55377-94.

Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo HW, Carpenter RL, Metheny-Barlow LJ, Zhou X, Qasem SA, Pasche B, Watabe K.. Cancer Res. 2016;76(17):4970-4980.

Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.. J Neurosurg. 2016;():.

Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Outcomes for metastatic melanoma treated with stereotactic radiosurgery in the era of targeted systemic therapies [abstract]. Henson A, McTyre E, Ayala-Peacock DN, Triozzi P, Savage P, Laxton AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E135-E136.

Multi-institutional competing risks analysis predicting distant brain failure and salvage patterns after upfront radiosurgery without whole-brain radiation therapy for brain metastasis [abstract]. McTyre E, Ayala-Peacock DN, Contessa JN, Chung C, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Attia A, Hepel JT, Braunstein SE, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180-S181.

Hippocampal dosimetry predicts for cancer-related cognitive impairment in patients treated with cranial radiation therapy: dosimetric results of a prospective clinical trial [abstract]. Okoukoni C, McTyre E, Peiffer AM, Hinson W, Strowd RE, Rapp S, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S90-S91.

Toxicity results of a phase 1 safety study of pioglitazone as a cytoprotective agent against radiation-induced cognitive decline [abstract]. Sullivan NA, Page BR, Peiffer AM, Isom S, Metheny-Barlow L, Brown DR, Blackstock AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E595.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

A phase II clinical trial of CPI-613 in patients with relapsed or refractory small cell lung carcinoma. Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J.. PLoS One. 2016;11(10):e0164244.

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. Hughes RT, Black PJ, Page BR, Lucas JT, Qasem SA, Watabe K, Ruiz J, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Radiosurg SBRT. 2016;4(2):89-96.

Predictors of trigeminal nerve dysfunction following stereotactic radiosurgery for trigeminal neuralgia. Lucas JT, Huang AJ, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2016;4(2):117-123.

Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Randolph DM II, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Clin Neurol Neurosurg. 2016;151():73-78.

Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation. Qian X, Tan H, Zhang J, Zhao W, Chan MD, Zhou X.. Med Phys. 2016;43(11):5889.

Upfront chemoradiotherapy in grade 2 low grade glioma, a single institution experience [abstract]. Wicks RT, Bandarage D, Mott RT, Strowd RE, Laxton AW, Tatter SB, Chan MD, Lesser GJ.. Neuro Oncol. 2016;18(Suppl 6):14.

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS.. Clin Cancer Res. 2015;21(2):286-294.

Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB.. J Clin Neurosci. 2015;22(3):561-565.

Roles of the cyclooxygenase 2-matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan M, Zhou X, Qasem S, Pochampally R, Mo YY, Watabe K.. J Biol Chem. 2015;290(15):9842-9854.

Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD.. J Neurosurg. 2015;122(3):536-542.

Anaplastic ganglioglioma: a report of three cases and review of the literature. Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD.. J Neurooncol. 2015;123(1):171-177.

Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Rapp SR, Case LD, Peiffer A, Naughton MM [sic] [Naughton MJ], Chan MD, Stieber VW, Moore DF Jr, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG.. J Clin Oncol. 2015;33(15):1653-1659.

Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD.. Neuro Oncol. 2015;17(10):1393-1401.

Recent technical advances and indications for radiation therapy in low-grade glioma. Chan MD.. Semin Radiat Oncol. 2015;25(3):189-196.

Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD.. Oncotarget. 2015;6(22):18945-55.

Repeat radiosurgery for trigeminal neuralgia. Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW.. Neurosurgery. 2015;77(5):755-761.

Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.

Factors that determine local control with gamma knife radiosurgery: the role of primary histology. Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD.. J Radiosurg SBRT. 2015;3(4):281-286.

Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2015;124(3):447-453.

A multi-institutional analysis of patients treated with stereotactic radiosurgery for brain metastases from radioresistant histologies [abstract]. Smith CA, McTyre E, Isom S, Kennedy VE, Luo G, Morales-Paliza M, Hinson W, Cmelak AJ, Tatter SB, Chan MD, Attia A.. Int J Radiat Oncol Biol Phys. 2015;93(3):E87-E88.

A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

Multi-institutional nomogram predicting survival free from salvage whole-brain radiation after radiosurgery for brain metastases [abstract]. Gorovets D, Ayala-Peacock DN, Tybor DJ, Rava PS, Ebner DK, Chan MD, Hepel JT.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E77.

A comprehensive assessment of radiographic, clinical, and treatment related risk factors for metastasis related intracranial hemorrhage in metastatic melanoma following radiation therapy [abstract]. Lucas JT Jr, Lack C, Wagner B, Kuremsky JG, Mu F, Chan MD, Sweeney A, Maldjian J, Whitlow C.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E111.

Impact of socioeconomic status on brain metastasis outcomes at a large academic radiosurgery center [abstract]. Houseknecht K, Taksler GB, Johnson A, Page BR, Hinson W, Laxton AW, Tatter SB, Weaver KE, Chan MD, Ruiz J.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E366.

The peroxisomal proliferator-activated receptor (PPAR) alpha agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Greene-Schloesser D, Payne V, Peiffer AM, Hsu FC, Riddle DR, Zhao W, Chan MD, Metheny-Barlow L, Robbins ME [deceased].. Radiat Res. 2014;181(1):33-44.

Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Cancer. 2014;120(3):433-441.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Radiation Oncology

Clinical Interests

Brain Tumors
Michael D. Chan, M.D.

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Doctor Rating

4.8 out of 5

Michael D. Chan, M.D.162 Ratings
12 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/17/2017

very good

6/20/2017

Dr. Chan was very professional and informative.

5/30/2017

Dr Chan is definitely the A team at Winston Salem

5/17/2017

Dr Chan was exceptional throughout.

5/13/2017

Dr. Chan is caring and compassionate.

3/29/2017

*Dr. Chan has been a wonderful partner in my health with cancer.

2/9/2017

I find *Doctor Chan to be very professional and caring provider. He seems concerned about his patient care and strives to do the best for them.

2/6/2017

We are very blessed to him at Baptist. *Dr. Michael Chan. 5. All of them. 9. He's the best. 10. We will.

1/7/2017

There is no better doctor than *Dr. Chan. He is the absolute best! He's caring, kind, compassionate & BRILLIANT!

12/21/2016

Very good.

11/23/2016

All went well.

10/11/2016

My experience with *Dr. Chas has been excellent!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.